Abstract |
Interleukin (IL)-9 belongs to the IL-2Rγc chain family and is a multifunctional cytokine that can regulate the function of many kinds of cells. It was originally identified as a growth factor of T cells and mast cells. In previous studies, IL-9 was mainly involved in the development of allergic diseases, autoimmune diseases and parasite infections. Recently, IL-9, as a double-edged sword in the development of cancers, has attracted extensive attention. Since T-helper 9 (Th9) cell-derived IL-9 was verified to play a powerful antitumor role in solid tumors, an increasing number of researchers have started to pay attention to the role of IL-9-skewed CD8+ T (Tc9) cells, mast cells and Vδ2 T cell-derived IL-9 in tumor immunity. Here, we review recent studies on IL-9 and several kinds of IL-9-producing cells in tumor immunity to provide useful insight into tumorigenesis and treatment. Video Abstract.
|
Authors | Jie Wan, Yinqiu Wu, Xiaoyun Ji, Lan Huang, Wei Cai, Zhaoliang Su, Shengjun Wang, Huaxi Xu |
Journal | Cell communication and signaling : CCS
(Cell Commun Signal)
Vol. 18
Issue 1
Pg. 50
(03 30 2020)
ISSN: 1478-811X [Electronic] England |
PMID | 32228589
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review, Video-Audio Media)
|
Chemical References |
- IL9 protein, human
- Interleukin-9
|
Topics |
- Animals
- CD8-Positive T-Lymphocytes
(cytology, immunology)
- Humans
- Interleukin-9
(immunology)
- Mast Cells
(cytology, immunology)
- Neoplasms
(immunology)
- T-Lymphocytes, Helper-Inducer
(cytology, immunology)
|